Boc-β-Lys(Z)-OH | 65581-30-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Boc-β-Lys(Z)-OH
• 英文别名: (S)-6-(benzyloxycarbonylamino)-3-(tert-butoxycarbonylamino)hexanoic acid；(3S)-6-{[(benzyloxy)carbonyl]amino}-3-[(tert-butoxycarbonyl)amino]hexanecarboxylic acid；(3S)-6-{[(Benzyloxy)carbonyl]amino}-3-[(tert-butoxycarbonyl)amino]hexanoic acid；(3S)-3-[(2-methylpropan-2-yl)oxycarbonylamino]-6-(phenylmethoxycarbonylamino)hexanoic acid
• CAS: 65581-30-8
• 化学式: C₁₉H₂₈N₂O₆
• 分子量: 380.441
• InChiKey: HNHAXXDXQQYOND-HNNXBMFYSA-N

物化性质

• 沸点：
  591.0±50.0 °C(Predicted)
• 密度：
  1.176±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  27
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  114
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  Boc-β-Lys(Z)-OH 在 palladium on activated charcoal 水 、 氢气 、 1-羟基苯并三唑 、 溶剂黄146 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 0.83h， 生成 4-[(S)-3-tert-butoxycarbonylamino-6-dimethylamino-hexanoyl]piperazine-1-carboxylic acid 9H-fluoren-9-ylmethyl ester
  参考文献：
  名称：

  Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB₂ Receptor Antagonists. 2. Synthesis and Structure−Activity Relationships of α,α-Cycloalkylglycine Sulfonamides

  摘要：

  Recently we reported on the design and synthesis of a novel class of selective nonpeptide bradykinin (BK) B-2 receptor antagonists (J. Med. Chem. 2006, 3602-3613). This work led to the discovery of MEN 15442, an antagonist with subnanomolar affinity for the human B2 receptor (hB2R), which also displayed significant and prolonged activity in vivo (for up to 210 min) against BK-induced bronchoconstriction in the guinea-pig at a dose of 300 nmol/kg (it), while demonstrating only a slight effect on BK-induced hypotension. Here we describe the further optimization of this series of compounds aimed at maximizing the effect on bronchoconstriction and minimizing the effect on hypotension, with a view to developing topically delivered drugs for airway diseases. The work led to the discovery of MEN 16132, a compound which, after intratracheal or aerosol administration, inhibited, in a dose-dependent manner, BK-induced bronchoconstricton in the airways, while showing minimal systemic activity. This compound was selected as a preclinical candidate for the topical treatment of airway diseases involving kinin B2 receptor stimulation.

  DOI：

  10.1021/jm061143k
• 作为产物：
  描述：

  ((S)-4-tert-Butoxycarbonylamino-6-diazo-5-oxo-hexyl)-carbamic acid benzyl ester 在 sodium hydroxide 、 silver(l) oxide 作用下， 以 甲醇 为溶剂， 生成 Boc-β-Lys(Z)-OH
  参考文献：
  名称：

  Peptidyl β-homo-aspartals: Specific inhibitors of interleukin-1β converting enzyme and its homologues (caspases)

  摘要：

  Inhibition of interleukin-1 beta converting enzyme (ICE), apopain, papain, thrombin and trypsin with substrate like peptidyl L- and D-alpha-aldehydes and their L-beta-homo-aldehyde analogues was investigated. The L-beta-homo-aspartals appear to be specific inhibitors for ICE and its homologues; the other enzymes were not inhibited with such L-beta-homo aldehydes. Papain shows tolerance for D-residues at P-1 depending on their chiral stability. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00244-3

文献信息

• Antibacterial amide macrocycles VII
  申请人：Endermann Rainer

  公开号：US20080306040A1

  公开（公告）日：2008-12-11

  The invention relates to antibacterial amide macrocycles and methods for their preparation, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially bacterial infections.

  这项发明涉及抗菌酰胺大环化合物及其制备方法，其用于治疗和/或预防疾病以及用于生产治疗和/或预防疾病的药物，特别是细菌感染的药物。
• COMPOUND HAVING READ-THROUGH ACTIVITY
  申请人：THE UNIVERSITY OF TOKYO

  公开号：US20140364642A1

  公开（公告）日：2014-12-11

  [Problem] Provision of a novel compound having read-through activity and a drug for the treatment of nonsense mutation-type disease containing this compound. [Solution] A compound represented by the following general formula (1): and a pharmaceutical composition containing this compound.

  一种具有读穿活性的新化合物以及包含该化合物的用于治疗无义突变型疾病的药物。 一种由以下一般式（1）表示的化合物： 以及含有该化合物的药物组合物。
• ANTIBACTERIAL AMIDE MACROCYCLES IV
  申请人：Endermann Rainer

  公开号：US20080076745A1

  公开（公告）日：2008-03-27

  The invention relates to antibacterial amide macrocycles and processes for their preparation, their use for the treatment and/or prophylaxis of diseases and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially bacterial infections.

  该发明涉及抗菌酰胺大环化合物及其制备过程，其用于治疗和/或预防疾病以及用于制造治疗和/或预防疾病，特别是细菌感染的药物。
• Compounds That Inhibit Replication Of Human Immunodeficiency Virus
  申请人：Balzarini Maria Rene Jan

  公开号：US20080076824A1

  公开（公告）日：2008-03-27

  The present invention relates to the discovery of a novel class of compounds that inhibit the replication of human immunodeficiency virus (HIV) and approaches to identify these compounds. More specifically, it has been found that enzymatically prepared alpha-hydroxyglycinamide and synthetically prepared alpha-hydroxyglycinamide inhibit the replication of HIV in human serum. Embodiments include methods to identify modified glycinamide compounds that inhibit HUV, methods to isolate and synthesize modified glycinamide compounds, and therapeutic compositions comprising these compounds.

  本发明涉及一种新型化合物类别的发现，该类化合物能够抑制人类免疫缺陷病毒（HIV）的复制，并提供了鉴定这些化合物的方法。具体来说，发现经酶法制备的α-羟基甘氨酰胺和人工合成的α-羟基甘氨酰胺能够抑制HIV在人血清中的复制。实施例包括鉴定抑制HUV的改性甘氨酰胺化合物的方法，分离和合成改性甘氨酰胺化合物的方法，以及包含这些化合物的治疗组合物。
• ANTIBACTERIAL AMIDE-MACROCYCLES V
  申请人：ENDERMANN Rainer

  公开号：US20080275018A1

  公开（公告）日：2008-11-06

  The invention relates to antibacterial amide-macrocycles of formula (I), in which R 26 represents hydrogen, halogen, amino or methyl, R 7 represents a group of formula (II), (III), (IV) or (V), whereby R 1 represents hydrogen or hydroxy and * is the linkage site to the carbon atom, R 2 represents hydrogen or methyl and methods for their production, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular of bacterial infections.

  本发明涉及式（I）的抗菌酰胺大环化合物，其中R26代表氢、卤素、氨基或甲基，R7代表式（II）、（III）、（IV）或（V）的基团，其中R1代表氢或羟基，*是连接到碳原子的连接位点，R2代表氢或甲基，以及它们的制备方法，它们用于治疗和/或预防疾病的用途，以及它们用于制备治疗和/或预防疾病的药物，特别是用于治疗细菌感染。